Security key
21217B100
Contineum Therapeutics, Inc. - Class A Common Stock, $0.001 par value per share (CTNM)
CUSIP: 21217B100
Q2 2025 13F Holders as of 30 Jun 2025
- Type / Class
- Equity / Class A Common Stock, $0.001 par value per share
- Shares outstanding
- 32,400,300
- Total 13F shares
- 13,856,430
- Share change
- -1,276,017
- Total reported value
- $55,287,652
- Price per share
- $3.97
- Number of holders
- 68
- Value change
- -$6,405,461
- Number of buys
- 37
- Number of sells
- 41
Report period
Q2 2025
Institutions
68
Top holders
10
CTNM full security history
Newer quarter: Q3 2025
Previous quarter: Q1 2025
Contineum Therapeutics, Inc. SEC filings
Contineum Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 21217B100
Recent filing periods:
Top shareholders of CTNM - Contineum Therapeutics, Inc. - Class A Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| SECTORAL ASSET MANAGEMENT INC |
13F
13D/G
|
Company · Jerome G. Pfund |
5%
from 13D/G
|
800,787
|
$5,589,493 | — | 31 Mar 2025 | |
| PERCEPTIVE ADVISORS LLC |
13F
13D/G
|
Company |
3.2%
from 13D/G
|
1,441,249
|
$10,059,918 | — | 31 Mar 2025 | |
| JOHNSON & JOHNSON |
3/4/5
13F
|
10%+ Owner · Company |
6.1%
from 13F
|
1,979,173
|
$33,744,900 | — | 09 Apr 2024 | |
| SUVRETTA CAPITAL MANAGEMENT, LLC |
13F
|
Company |
5.3%
|
1,720,000
|
$12,005,600 | — | 31 Mar 2025 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
4.9%
|
1,576,181
|
$11,001,743 | — | 31 Mar 2025 | |
| Versant Venture Management, LLC |
13F
|
Company |
2.8%
|
918,163
|
$6,408,778 | — | 31 Mar 2025 | |
| FMR LLC |
13F
|
Company |
2.5%
|
810,317
|
$5,656,013 | — | 31 Mar 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
2.5%
|
803,428
|
$5,607,928 | — | 31 Mar 2025 | |
| HHLR ADVISORS, LTD. |
13F
|
Company |
2.1%
|
669,337
|
$4,671,972 | — | 31 Mar 2025 | |
| Red Tree Management, LLC |
13F
|
Company |
2%
|
638,158
|
$4,454,343 | — | 31 Mar 2025 | |
| BlackRock, Inc. |
13F
|
Company |
1.9%
|
616,624
|
$4,304,034 | — | 31 Mar 2025 | |
| Samsara BioCapital, LLC |
13F
|
Company |
1.8%
|
588,816
|
$4,109,936 | — | 31 Mar 2025 | |
| Saturn V Capital Management LP |
13F
|
Company |
1.7%
|
560,979
|
$3,915,633 | — | 31 Mar 2025 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
0.96%
|
312,500
|
$2,181,250 | — | 31 Mar 2025 | |
| Altium Capital Management LLC |
13F
|
Company |
0.94%
|
303,857
|
$2,120,922 | — | 31 Mar 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.6%
|
193,051
|
$1,347,716 | — | 31 Mar 2025 | |
| NORGES BANK |
13F
|
Company |
0.52%
|
169,729
|
$1,184,708 | — | 31 Mar 2025 | |
| ADAR1 Capital Management, LLC |
13F
|
Company |
0.52%
|
168,765
|
$1,177,980 | — | 31 Mar 2025 | |
| Casdin Capital, LLC |
13F
|
Company |
0.46%
|
148,333
|
$1,035,364 | — | 31 Mar 2025 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.44%
|
142,200
|
$992,556 | — | 31 Mar 2025 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.4%
|
131,027
|
$914,568 | — | 31 Mar 2025 | |
| STATE STREET CORP |
13F
|
Company |
0.39%
|
126,864
|
$885,511 | — | 31 Mar 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.26%
|
83,626
|
$583,709 | — | 31 Mar 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.18%
|
57,157
|
$398,957 | — | 31 Mar 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.16%
|
51,202
|
$357,390 | — | 31 Mar 2025 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
0.13%
|
42,499
|
$300,468 | — | 31 Mar 2025 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.1%
|
31,084
|
$216,966 | — | 31 Mar 2025 | |
| Strategies Wealth Advisors, LLC |
13F
|
Company |
0.08%
|
25,000
|
$174,500 | — | 31 Mar 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.06%
|
19,899
|
$138,895 | — | 31 Mar 2025 | |
| Dynamic Technology Lab Private Ltd |
13F
|
Company |
0.05%
|
16,838
|
$118,000 | — | 31 Mar 2025 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.05%
|
16,079
|
$112,231 | — | 31 Mar 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.04%
|
14,221
|
$99,263 | — | 31 Mar 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.04%
|
13,307
|
$92,883 | — | 31 Mar 2025 | |
| UBS Group AG |
13F
|
Company |
0.04%
|
13,294
|
$92,792 | — | 31 Mar 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.04%
|
13,257
|
$92,534 | — | 31 Mar 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0.03%
|
11,083
|
$77,359 | — | 31 Mar 2025 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.03%
|
10,877
|
$75,922 | — | 31 Mar 2025 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.02%
|
7,573
|
$52,852 | — | 31 Mar 2025 | |
| CITIGROUP INC |
13F
|
Company |
0.02%
|
7,387
|
$51,561 | — | 31 Mar 2025 | |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. |
13F
|
Company |
0.02%
|
6,094
|
$42,536 | — | 31 Mar 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.02%
|
5,769
|
$40,268 | — | 31 Mar 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.02%
|
5,167
|
$36,066 | — | 31 Mar 2025 | |
| Corebridge Financial, Inc. |
13F
|
Company |
0.02%
|
5,139
|
$35,870 | — | 31 Mar 2025 | |
| STRS OHIO |
13F
|
Company |
0.01%
|
3,900
|
$27,222 | — | 31 Mar 2025 | |
| Legal & General Group Plc |
13F
|
Company |
0.01%
|
3,631
|
$25,344 | — | 31 Mar 2025 | |
| Police & Firemen's Retirement System of New Jersey |
13F
|
Company |
0%
|
1,396
|
$9,744 | — | 31 Mar 2025 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
1,358
|
$9,479 | — | 31 Mar 2025 | |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM |
13F
|
Company |
0%
|
783
|
$5,465 | — | 31 Mar 2025 | |
| Ameritas Investment Partners, Inc. |
13F
|
Company |
0%
|
680
|
$4,746 | — | 31 Mar 2025 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0%
|
628
|
$4,383 | — | 31 Mar 2025 |
Institutional Holders of Contineum Therapeutics, Inc. - Class A Common Stock, $0.001 par value per share (CTNM) as of Q2 2025
As of 30 Jun 2025,
Contineum Therapeutics, Inc. - Class A Common Stock, $0.001 par value per share (CTNM) was held by
68 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
13,856,430 shares.
The largest 10 holders included
JOHNSON & JOHNSON, SUVRETTA CAPITAL MANAGEMENT, LLC, FRANKLIN RESOURCES INC, FMR LLC, SECTORAL ASSET MANAGEMENT INC, VANGUARD GROUP INC, PERCEPTIVE ADVISORS LLC, HHLR ADVISORS, LTD., RED TREE MANAGEMENT, LLC, and SAMSARA BIOCAPITAL, LLC.
This page lists
69
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
62
Q2 2025 holders
68
Holder diff
6
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.